PT Kalbe Farma Tbk (PTKFF)
0.0926
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
PT Kalbe Farma Shareholders Equity (Quarterly): 1.410B for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.410B |
December 31, 2023 | 1.371B |
September 30, 2023 | 1.344B |
June 30, 2023 | 1.327B |
March 31, 2023 | 1.420B |
December 31, 2022 | 1.305B |
September 30, 2022 | 1.285B |
June 30, 2022 | 1.276B |
March 31, 2022 | 1.417B |
December 31, 2021 | 1.371B |
September 30, 2021 | 1.281B |
June 30, 2021 | 1.217B |
March 31, 2021 | 1.245B |
December 31, 2020 | 1.218B |
September 30, 2020 | 1.143B |
June 30, 2020 | 1.144B |
March 31, 2020 | 1.134B |
December 31, 2019 | 1.144B |
September 30, 2019 | 1.073B |
June 30, 2019 | 1.041B |
March 31, 2019 | 1.065B |
December 31, 2018 | 1.009B |
September 30, 2018 | 933.57M |
June 30, 2018 | 920.43M |
March 31, 2018 | 1.013B |
Date | Value |
---|---|
December 31, 2017 | 982.78M |
September 30, 2017 | 937.29M |
June 30, 2017 | 907.33M |
March 31, 2017 | 937.40M |
December 31, 2016 | 881.29M |
September 30, 2016 | 869.98M |
June 30, 2016 | 815.82M |
March 31, 2016 | 826.56M |
December 31, 2015 | 753.49M |
September 30, 2015 | 682.18M |
June 30, 2015 | 717.75M |
March 31, 2015 | 754.38M |
December 31, 2014 | 746.41M |
September 30, 2014 | 721.79M |
June 30, 2014 | 689.22M |
March 31, 2014 | 755.77M |
December 31, 2013 | 663.28M |
September 30, 2013 | 649.94M |
June 30, 2013 | 709.14M |
March 31, 2013 | 773.06M |
December 31, 2012 | 726.57M |
September 30, 2012 | 682.82M |
June 30, 2012 | 650.40M |
March 31, 2012 | 722.97M |
December 31, 2011 | 677.42M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.041B
Minimum
Jun 2019
1.420B
Maximum
Mar 2023
1.258B
Average
1.279B
Median
Shareholders Equity (Quarterly) Benchmarks
Taihe Group Inc | -0.0632M |
CEL-SCI Corp | 14.30M |
AIM ImmunoTech Inc | 10.23M |
IGC Pharma Inc | 9.053M |
NovaBay Pharmaceuticals Inc | 0.16M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.824B |
Total Liabilities (Quarterly) | 305.45M |
Debt to Equity Ratio | 0.0295 |
Current Ratio | 4.313 |
Net Debt Paydown Yield | 0.14% |